Assignee
ACCERA INC
US·4 granted patents·8 pending applications·187 citations·filing 2002–2017
Top patents by PatentIndex Score
12 records- 0197US6835750B1Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism IIACCERA INC·Filed 2002·Granted Dec 28, 2004·178 cites·4 claims
- 0293US10111849B2Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism IIACCERA INC·Filed 2017·Granted Oct 30, 2018·7 cites·16 claims
- 0383US9603823B2Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism IIACCERA INC·Filed 2013·Granted Mar 28, 2017·2 cites·6 claims
- 0459US2010041751A1Method to Reduce Oxidative Damage and Improve Mitochondrial EfficiencyACCERA INC·Filed 2009·Application pending·0 cites
- 0557US2008009467A1Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolismACCERA INC·Filed 2007·Application pending·0 cites
- 0656US2014256808A1Use of Ketogenic Compounds for Treatment of Age-Associated Memory ImpairmentACCERA INC·Filed 2014·Application pending·0 cites
- 0754US10105338B2Use of genomic testing and ketogenic compounds for treatment of reduced cognitive functionACCERA INC·Filed 2015·Granted Oct 23, 2018·0 cites·6 claims
- 0853US2013005693A1Method for Reducing Levels of Disease Associated ProteinsACCERA INC·Filed 2012·Application pending·0 cites
- 0952US2007179197A1Compositions and methods for improving or preserving brain functionACCERA INC·Filed 2006·Application pending·0 cites
- 1051US2007135376A1Method to reduce oxidative damage and improve mitochondrial efficiencyACCERA INC·Filed 2006·Application pending·0 cites
- 1143US2010261791A1Compositions and Methods for Improving or Preserving Brain FunctionACCERA INC·Filed 2010·Application pending·0 cites
- 1243US2003059824A1Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolismACCERA INC·Filed 2002·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →